| [1] |
Berktaçs BM, Gökçek A, Hoca NT, et al. COVID-19 illness and treatment decrease bone mineral density of surviving hospitalized patients[J]. Eur Rev Med Pharmacol Sci, 2022, 26(8): 3046-3056.
|
| [2] |
Barrea L, Grant WB, Frias-Toral E, et al. Dietary recommendations for post-COVID-19 syndrome[J]. Nutrients, 2022, 14(6): 1305.
doi: 10.3390/nu14061305
URL
|
| [3] |
Bandeira L, Lazaretti-Castro M, Binkley N. Clinical aspects of SARS-CoV-2 infection and vitamin D: COVID-19 and the endocrine system[J]. Rev Endocr Metab Disord, 2022, 23(2): 287-291.
doi: 10.1007/s11154-021-09683-9
URL
|
| [4] |
Qiao W, Lau HE, Xie H, et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters[J]. Nat Commun, 2022, 13(1): 2539.
doi: 10.1038/s41467-022-30195-w
pmid: 35534483
|
| [5] |
Battisti S, Napoli N, Pedone C, et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency[J]. Endocrine, 2021, 74(3): 461-469.
doi: 10.1007/s12020-021-02872-1
URL
|
| [6] |
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华内分泌代谢杂志, 2017, 33(10): 890-913.
|
| [7] |
中国营养学会骨营养与健康分会, 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症患者的营养和运动管理专家共识[J]. 中华内分泌代谢杂志, 2020, 36(8):643-653.
|
| [8] |
Leandro CG, Ferreira E, Silva WT, et al. Covid-19 and Exercise-Induced Immunomodulation[J]. Neuroimmuno-modulation, 2020, 27(1): 75-78.
|
| [9] |
Morais AHA, Aquino JS, da Silva-Maia JK, et al. Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2[J]. Br J Nutr, 2021, 125: 851-862.
doi: 10.1017/S0007114520003311
URL
|
| [10] |
杨嫣琼, 张巧, 彭年春, 等. 睡眠时长、入睡时间与绝经后女性骨质疏松风险的相关性研究[J]. 中华内分泌代谢杂志, 2020, 36(11): 949-955.
|
| [11] |
di Filippo L, Frara S, Doga M, et al. The osteo-metabolic phenotype of COVID-19: an update[J]. Endocrine, 2022, 78(2): 247-254.
doi: 10.1007/s12020-022-03135-3
URL
|
| [12] |
Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with vitamin D deficiency[J]. Nutrition, 2021, 84:111106.
|
| [13] |
Elamir YM, Amir H, Lim S, et al. A randomized pilot study using calcitriol in hospitalized COVID-19 patients[J]. Bone, 2022, 154: 116175.
doi: 10.1016/j.bone.2021.116175
URL
|
| [14] |
Artero A, Tarín JJ, Cano A. The adverse effects of estrogen and selective estrogen receptor modulators on hemostasis and thrombosis[J]. Semin Thromb Hemost, 2012, 38(8): 797-807.
doi: 10.1055/s-0032-1328883
pmid: 23111860
|
| [15] |
Atmaca A, Demirci I, Haymana C, et al. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study[J]. Osteoporos Int, 2022, 33(1): 273-282.
doi: 10.1007/s00198-021-06067-2
URL
|
| [16] |
Lv H, Zhang Q, Yin Y, et al. Epidemiologic characteristics of traumatic fractures during the outbreak of corona-virus disease 2019(COVID-19) in China[J]. Injury, 2020, 51(8): 1698-1704.
doi: 10.1016/j.injury.2020.06.022
URL
|
| [17] |
Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid[J]. J Clin Endocrinol Metab, 2010, 95(9): 4380-4387.
doi: 10.1210/jc.2010-0597
pmid: 20554708
|
| [18] |
Letizia AG, Ramos I, Obla A, et al. SARS-CoV-2 transmission among marine recruits during quarantine[J]. N Engl J Med, 2020, 383(25): 2407-2416.
doi: 10.1056/NEJMoa2029717
URL
|
| [19] |
Blanch-Rubió J, Soldevila-Domenech N, Tío L, et al. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions[J]. Aging (Albany NY), 2020, 12(20):19923-19937.
|
| [20] |
Gonzalez-Rodriguez E, Aubry-Rozier B, Stoll D, et al. Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors[J]. Breast Cancer Res Treat, 2020, 179(1):153-159.
doi: 10.1007/s10549-019-05458-8
URL
|
| [21] |
Tan YL, Tan KSW, Chu JJH, et al. Combination treatment with remdesivir and ivermectin exerts highly synergistic and potent antiviral activity against murine corona-virus infection[J]. Front Cell Infect Microbiol, 2021, 11: 700502.
doi: 10.3389/fcimb.2021.700502
URL
|
| [22] |
Wu Q, Zhou X, Huang D, et al. IL-6 Enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro[J]. Cell Physiol Biochem, 2017, 41: 1360-1369.
doi: 10.1159/000465455
URL
|
